702 filings
Page 23 of 36
8-K
bp9u5ncohre qj6wm
28 Aug 12
Acorda Therapeutics Announces GGF2 Preclinical Data on Treatment of Erectile Dysfunction
12:00am
8-K
5nelu8z4rh tcotu4
13 Aug 12
Acorda Therapeutics Announces Top Line Results of Post-Marketing Commitment Study Exploring 5 mg Dose of Dalfampridine-ER
12:00am
8-K
qo206zu8x468c2r82qb
31 Jul 12
Acorda Therapeutics Reports Second Quarter 2012 Financial Results
12:00am
8-K
irf syg4hsmuz0
12 Jun 12
Acorda Therapeutics Announces Initiation of AMPYRA® Proof-of-Concept Study in Patients with Post-Stroke Deficits
12:00am
CT ORDER
uqeq cdgm
11 Jun 12
Confidential treatment order
12:00am
8-K
zebmuk
7 Jun 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
z5gv7axtkw
31 May 12
Other Events
12:00am
8-K
8wtayx59qntkj6
31 May 12
Other Events
12:00am
8-K
afiy7
3 May 12
Acorda Therapeutics Reports First Quarter 2012 Financial Results
12:00am
8-K
1jy ouql6j2
25 Apr 12
Acorda Therapeutics Presents AMPYRA® Long-Term Safety and Efficacy Data at 64th American Academy of Neurology Annual Meeting
12:00am
S-8
tycmjgus k16ub7sk
5 Mar 12
Registration of securities for employees
12:00am
8-K
rq40cqv0ymv08oyl5
16 Feb 12
Acorda Therapeutics Reports Fourth Quarter and Full Year 2011 Financial Results
12:00am
8-K
qi5xqvf
6 Feb 12
Other Events
12:00am
8-K
k80cwu5 fkgs
3 Feb 12
Other Events
12:00am
8-K
yu0cr2r vksdgv2x
9 Jan 12
Acorda Therapeutics Provides 2012 Corporate Update at 30th Annual J.P. Morgan Healthcare Conference
12:00am
8-K
0ij2h
21 Dec 11
Amendments to Articles of Incorporation or Bylaws
12:00am